We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
76 hedge funds and large institutions have $124M invested in GALENA BIOPHARMA INC COM in 2013 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
205% more capital invested
Capital invested by funds: $40.5M → $124M (+$83.2M)
59% more call options, than puts
Call options by funds: $17M | Put options by funds: $10.7M
43% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 21
21% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 14
4% more funds holding
Funds holding: 73 → 76 (+3)
Holders
76
Holders Change
+3
Holders Change %
+4.11%
% of All Funds
2.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
30
Reduced
21
Closed
14
Calls
$17M
Puts
$10.7M
Net Calls
+$6.34M
Net Calls Change
+$5.41M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$20.4M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$14.8M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
+$1.55M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.24M |
| 5 |
Morgan Stanley
New York
|
+$1.06M |
